Jim Cramer Prefers Intuitive Surgical, Inc. (NASDAQ:ISRG) Over Procept Biorobotics
Is Procept Biorobotics Corp. (PRCT) the Worst AI Stock to Buy?
Procept Biorobotics Corporation (PRCT): Why Are Short Sellers Betting Against This Hospital Tech Innovator?
Procept Biorobotics Insider Sold Shares Worth $2,062,679, According to a Recent SEC Filing
Form 144 | PROCEPT BioRobotics(PRCT.US) Insider Proposes to Sell 4.06 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 16, $PROCEPT BioRobotics(PRCT.US)$ Insider Kevin Waters intends to sell 50,000 shares of its common stock on Sep 16, with a total market value of approximately $4.06
PROCEPT BioRobotics Currently Up Nine Consecutive Days, Longest Winning Streak Since September 2023 -- Data Talk
PROCEPT BioRobotics Is Maintained at Buy by TD Cowen
PROCEPT BioRobotics Analyst Ratings
Express News | Procept Biorobotics Corp : TD Cowen Raises Target Price to $99 From $75
TD Cowen Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Raises Target Price to $99
TD Cowen analyst Josh Jennings maintains $PROCEPT BioRobotics(PRCT.US)$ with a buy rating, and adjusts the target price from $75 to $99.According to TipRanks data, the analyst has a success rate of 56
Buy Rating Affirmed for PROCEPT BioRobotics on Hydros Platform Launch and Positive Long-Term Growth Outlook
Is PROCEPT BioRobotics (NASDAQ:PRCT) Using Too Much Debt?
PROCEPT BioRobotics(PRCT.US) Director Sells US$9.38 Million in Common Stock
$PROCEPT BioRobotics(PRCT.US)$ Director Desai Antal Rohit sold 120.07K shares of common stock on Sep 10, 11, 12, 2024 at an average price of $78.0877 for a total value of $9.38 million.Source:
Northside Hospital Forsyth and Georgia Urology First in World to Offer Next-Generation, AI-Powered Treatment of Enlarged Prostate
Procept BioRobotics Insider Sold Shares Worth $7,741,893, According to a Recent SEC Filing
PROCEPT BioRobotics(PRCT.US) Director Sells US$7.74 Million in Common Stock
$PROCEPT BioRobotics(PRCT.US)$ Director Desai Antal Rohit sold 102.16K shares of common stock on Sep 3, 4, 5, 2024 at an average price of $75.7843 for a total value of $7.74 million.Source:
Form 144 | PROCEPT BioRobotics(PRCT.US) Director Proposes to Sell 12.73 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 4, $PROCEPT BioRobotics(PRCT.US)$ Director 222 DNA TRUST intends to sell 169.58K shares of its common stock on Sep 4, with a total market value of approximately $12.73
Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good'
Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $95
Truist Financial analyst Richard Newitter maintains $PROCEPT BioRobotics(PRCT.US)$ with a buy rating, and maintains the target price at $95.According to TipRanks data, the analyst has a success rate
Form 144 | PROCEPT BioRobotics(PRCT.US) Director Proposes to Sell 4.16 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 3, $PROCEPT BioRobotics(PRCT.US)$ Director ANTAL ROHIT DESAI intends to sell 52,640 shares of its common stock on Sep 3, with a total market value of approximately $4.16